Condition
Relapsed/Refractory Large B-cell Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Relapsed/Refractory Large B-cell Lymphoma clinical trials that are recruiting, at sites in 3 countries (most in China (3), Australia (1), United States (1)). By phase: Phase 2 (3), Phase 1/2 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Relapsed/Refractory Large B-cell Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Glofit-GemOx Bridging to Liso-cel for Relapsed/Refractory Large B-Cell Lymphoma | Phase 2 | Boston, Massachusetts and 1 other locations | Recruiting | Jul 17, 2026 |
| Automated CAR-T Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma | Early Phase 1 | Beijing, Beijing Municipality and 5 other locations | Recruiting | May 26, 2026 |
| Linperlisib with immunochemotherapy for relapsed large B-cell lymphoma | Phase 2 | Tianjin, Tianjin Municipality | Recruiting | Jul 8, 2024 |
| Epcoritamab treatment for patients with large B-cell lymphoma after CAR T-cell therapy | Phase 2 | Camperdown, New South Wales and 5 other locations | Recruiting | May 16, 2024 |
| Evaluating Prizloncabtagene Autoleucel for patients with relapsed/refractory large B-cell lymphoma | Phase 1/2 | Beijing and 14 other locations | Recruiting | Apr 6, 2023 |
All recruiting trials (5)
-
Glofit-GemOx Bridging to Liso-cel for Relapsed/Refractory Large B-Cell Lymphoma
This trial tests whether a bridging therapy with Glofit-GemOx followed by lisocabtagene maraleucel helps people with relapsed or refractory large B-cell lymphoma.
-
Automated CAR-T Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma
This trial tests an automated CAR-T cell therapy called FKC876 for adults with relapsed or refractory large B-cell lymphoma as a second-line treatment.
-
Linperlisib with immunochemotherapy for relapsed large B-cell lymphoma
This study is testing if adding Linperlisib to standard immunochemotherapy helps people with relapsed large B-cell lymphoma feel better and have more treatment options.
-
Epcoritamab treatment for patients with large B-cell lymphoma after CAR T-cell therapy
This study is testing if a new treatment called Epcoritamab, either on its own or with two other drugs, can help patients with large B-cell lymphoma who haven't responded well after CAR T-cell therapy.
-
Evaluating Prizloncabtagene Autoleucel for patients with relapsed/refractory large B-cell lymphoma
This study is testing a new treatment called Prizloncabtagene Autoleucel to see if it can help people with relapsed or hard-to-treat large B-cell lymphoma.
Related topics
Quick answers
How many Relapsed/Refractory Large B-cell Lymphoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), Australia (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.